Contact Us

Innoforce has created a unique partnership model that sits alongside but also complements our Advanced Therapies Solutions CDMO and InnoAccelerator businesses.


Through our partnerships we can provide access to a wide range of resources, including venture management expertise, product development support, and equity investment.


Partners can benefit from our industry leadership team’s vast experience and guidance, access to our industry-leading development and manufacturing facilities, as well as our global reach. Innoforce currently has established  a number of partnerships to develop our capabilities across the development cycle


We use a bespoke approach for each potential partner, evaluating together to develop the most appropriate approach for each partner’s success.

Representative Partnerships


If you are interested in partnering with Innoforce, please contact us .

Thermo Fisher Biopharma Service (Hangzhou) is a joint venture between Innoforce & Thermo Fisher Scientific, offering CDMO services for antibody drugs.


Together we are currently developing a state-of-the-art GMP facility that will become part of Thermo Fisher Scientific’s extensive global pharma services network. The facility is designed for integrated biologics and sterile drug development and manufacturing, and is completed in 2022.

Innoforce campus

The facility will include world-leading capabilities for drug product development, biologics manufacturing, sterile fill-finish, clinical trials packaging and logistics. The Hangzhou site will also incorporate stringent quality control processes that meet regulatory guidelines established by the China National Medical Products Administration (NMPA), the U.S. FDA and appropriate EMEA authorities.

More details can be found on
Thermo Fisher Scientific’s website .


Innoforce is also planning an integrated BioPark at our campus in Hangzhou, China to offer modern space and facility service for life science companies.

keywords:mRNA CDMO mRNA CDMO